AptaBio Therapeutics Stock Forecast - Accumulation Distribution
293780 Stock | 7,200 60.00 0.84% |
AptaBio Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast AptaBio Therapeutics stock prices and determine the direction of AptaBio Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of AptaBio Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
AptaBio |
Most investors in AptaBio Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the AptaBio Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets AptaBio Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
The accumulation distribution (A/D) indicator shows the degree to which AptaBio Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of AptaBio Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by AptaBio Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.Previous Accumulation Distribution | Accumulation Distribution | Trend |
63820.79 | 23847.08 |
Check AptaBio Therapeutics Volatility | Backtest AptaBio Therapeutics | Information Ratio |
AptaBio Therapeutics Trading Date Momentum
On June 11 2024 AptaBio Therapeutics was traded for 7,200 at the closing time. The highest price during the trading period was 7,200 and the lowest recorded bid was listed for 6,770 . The volume for the day was 399.3 K. This history from June 11, 2024 did not affect price variability. The overall trading delta to the current price is 2.64% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare AptaBio Therapeutics to competition |
Other Forecasting Options for AptaBio Therapeutics
For every potential investor in AptaBio, whether a beginner or expert, AptaBio Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AptaBio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AptaBio. Basic forecasting techniques help filter out the noise by identifying AptaBio Therapeutics' price trends.AptaBio Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AptaBio Therapeutics stock to make a market-neutral strategy. Peer analysis of AptaBio Therapeutics could also be used in its relative valuation, which is a method of valuing AptaBio Therapeutics by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
AptaBio Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of AptaBio Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of AptaBio Therapeutics' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
AptaBio Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how AptaBio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AptaBio Therapeutics shares will generate the highest return on investment. By undertsting and applying AptaBio Therapeutics stock market strength indicators, traders can identify AptaBio Therapeutics entry and exit signals to maximize returns.
Accumulation Distribution | 23847.08 | |||
Daily Balance Of Power | 0.1395 | |||
Rate Of Daily Change | 1.01 | |||
Day Median Price | 6985.0 | |||
Day Typical Price | 7056.67 | |||
Market Facilitation Index | 0.0011 | |||
Price Action Indicator | 245.0 | |||
Period Momentum Indicator | 60.0 |
AptaBio Therapeutics Risk Indicators
The analysis of AptaBio Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AptaBio Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aptabio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 2.9 | |||
Semi Deviation | 2.53 | |||
Standard Deviation | 5.03 | |||
Variance | 25.28 | |||
Downside Variance | 8.26 | |||
Semi Variance | 6.38 | |||
Expected Short fall | (3.35) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in AptaBio Stock
AptaBio Therapeutics financial ratios help investors to determine whether AptaBio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AptaBio with respect to the benefits of owning AptaBio Therapeutics security.